Good morning, everyone, and welcome to ANI's First Quarter 2019 Earnings Call. (Operator Instructions) Please note, this call may be recorded. It is now my pleasure to turn today's program over to Mr.

Though ANI Pharmaceuticals’s net revenue grew $5 million in 2019, the company logged a nearly $24 million increase in spending. According to ANI’s annual report released Thursday, the company logged ...

Check out the speakers and information sessions that HealthLeaders is looking forward to at the 2019 HFMA ANI conference in Orlando. HealthLeaders will be attending the Healthcare Financial Management ...

ANI Pharmaceuticals (ANIP) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...

ANI continue to post strong results in the second quarter of 2019, posting 15% year-over-year net revenue growth and record quarterly adjusted net GAAP EBITDA of $23.7 million. Corresponding adjusted ...